Fangzhou Inc. Denies Knowledge of Share Price Surge

Reuters01-13
Fangzhou Inc. Denies Knowledge of Share Price Surge

Fangzhou Inc. has issued an announcement in response to recent press articles highlighting its previously announced strategic collaboration with Tencent Healthcare. The company clarified that this collaboration is part of its routine, ordinary, and usual course of business. After making reasonable enquiries, the board confirmed that it is not aware of any reasons for the recent increase in the trading price of its shares or any information that must be announced to avoid a false market in the company’s securities. The company also stated that there is no inside information that needs to be disclosed under the relevant listing rules and regulations. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260113-11989575), on January 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment